"10.1371_journal.pone.0044469","none","2012-08-31T00:00:00Z","Elisa Bruno; Karamoko Nimaga; Ibrahima Foba; Philippe Vignoles; Pierre Genton; Ogobara Doumbo; Daniel Gérard; Pierre-Marie Preux; Guy Farnarier","Institut National de la Santé et de la Recherche Médicale (INSERM) U1094, Tropical Neuroepidemiology, University of Limoges, School of Medicine, Institute of Tropical Neurology, Centre Hospitalier Universitaire (CHU), Limoges, France; Department Gian Filippo Ingrassia, Section of Neurosciences, University of Catania, Catania, Italy; Association des Médecins de Campagne/Réseau Action-Recherche sur l’Epilepsie (RARE) Network, Bamako, Mali; Department of Epidemiology of Parasitic Diseases, Faculty of Medicine, Bamako, Mali; Santé-Sud Non-Governmental Organization, Bamako, Mali and Marseille, France; Access to Drugs Department, Sanofi-Aventis, Paris, France; Department of Clinical Neurophysiology, Community Health Research Unit (CHRU) Hôpital Nord and Faculty of Medicine/Aix-Marseille University, Marseille, France","Conceived and designed the experiments: PG OD GF. Performed the experiments: PG OD GF IF. Analyzed the data: EB PV PMP. Contributed reagents/materials/analysis tools: KN DG. Wrote the paper: EB PMP GF.","This work was supported by Sanofi-Aventis within the project “RARE: Réseau Action-Recherche sur l’Epilepsie” coordinated by the NGO Santé-Sud. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials. Dr. Karamoko Nimaga and Dr. Ibrahima Foba are affiliated to the Association des Médecins de Campagne/RARE Network. Dr. Pierre Genton, Dr. Ogobara Doumbo and Dr. Guy Farnarier declare to be affiliated to the nongovernmental organization Santé-Sud. Dr. Daniel Gérard declares to be employed for Sanofi-Aventis. These above-mentioned affiliations do not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","08","Elisa Bruno","EB",9,TRUE,3,4,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
